Palisade Bio Files Q1 2025 10-Q
Ticker: PALI · Form: 10-Q · Filed: May 12, 2025 · CIK: 1357459
| Field | Detail |
|---|---|
| Company | Palisade Bio, Inc. (PALI) |
| Form Type | 10-Q |
| Filed Date | May 12, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, biotech, equity
TL;DR
Palisade Bio's Q1 2025 10-Q is in, check out their lease, RSUs, and May '24 offering.
AI Summary
Palisade Bio, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported on its financial condition and business operations, including details on its office space lease in Carlsbad, CA, and its equity incentive plan involving Restricted Stock Units (RSUs). The filing also references a May 2024 offering and placement agent warrants.
Why It Matters
This filing provides insight into Palisade Bio's financial health and operational activities during the first quarter of 2025, which is crucial for investors assessing the company's trajectory.
Risk Assessment
Risk Level: medium — As a biotech company, Palisade Bio faces inherent risks related to drug development, regulatory approvals, and market competition, which are reflected in its financial filings.
Key Numbers
- 20250331 — Reporting Period End Date (Indicates the end of the fiscal quarter for this 10-Q filing.)
- 20250512 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
Key Players & Entities
- Palisade Bio, Inc. (company) — Filer of the 10-Q
- March 31, 2025 (date) — End of the reporting period
- 7750 El Camino Real, Suite 5200, Carlsbad, CA 92009 (location) — Company's business and mailing address
- May 6, 2024 (date) — Date of the May Two Thousand Twenty Four Offering
FAQ
What is the company's primary business focus as indicated by its SIC code?
The company's Standard Industrial Classification (SIC) code is 2836, indicating its business is in Biological Products (No Diagnostic Substances).
What significant events or offerings are mentioned in the filing period?
The filing mentions a 'May Two Thousand Twenty Four Offering' that occurred on May 6, 2024, and 'Placement Agent Warrants' from January 30, 2024.
What specific equity-related plans are detailed in the filing?
The filing details the company's 'Equity Incentive Plan' and specifically mentions 'Restricted Stock Units (RSUs)' for the periods of January 1, 2025, to March 31, 2025, and January 1, 2024, to March 31, 2024.
Where is Palisade Bio, Inc. headquartered?
Palisade Bio, Inc.'s business and mailing address is located at 7750 El Camino Real, Suite 5200, Carlsbad, CA 92009.
What is the company's fiscal year end?
The company's fiscal year ends on December 31st.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 12, 2025 regarding PALISADE BIO, INC. (PALI).